We found that LPS promotes the proliferation and drug resistance of glioma CD133+ CSCs and leads to immune evasion of CD133+ CSCs from cytotoxic T lymphocyte-induced cytolysis. The gene discussed is PROM1; the disease is central nervous system cancer.